- Home
- CCD vs SIBN Comparison
CCD vs SIBN Comparison
Compare CCD & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCD | SIBN |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 662.0M | 674.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CCD | SIBN |
|---|---|---|
| Price | $25.77 | $16.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $23.88 |
| AVG Volume (30 Days) | 74.8K | ★ 471.1K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 10.61% | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $16.95 |
| Revenue Next Year | N/A | $14.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $19.99 | $11.48 |
| 52 Week High | $26.10 | $21.89 |
Technical Indicators
Market Signals| Indicator | CCD | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 57.79 | 59.13 |
| Support Level | $20.38 | $14.62 |
| Resistance Level | $25.81 | $17.13 |
| Average True Range (ATR) | 0.60 | 0.68 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 90.62 | 51.92 |
Price Performance
Historical ComparisonAbout CCD Calamos Dynamic Convertible & Income Fund
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.